NLRP3 and pyroptosis blockers for treating inflammatory diseases
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference118 articles.
1. Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950;Corcoran;Pharmacol. Rev.,2021
2. Targeting the NLRP3 inflammasome in inflammatory diseases;Mangan;Nat. Rev. Drug Discov.,2018
3. Toward targeting inflammasomes: insights into their regulation and activation;Christgen;Cell Res.,2020
4. The gasdermins, a protein family executing cell death and inflammation;Broz;Nat. Rev. Immunol.,2020
5. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response;Baroja-Mazo;Nat. Immunol.,2014
Cited by 300 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protective role of TRPM7 knockdown in ulcerative colitis via blocking NLRP3 inflammasome-mediated pyroptosis;Prostaglandins & Other Lipid Mediators;2024-12
2. Tyrobp deficiency blocks NLRP3-mediated inflammation and pyroptosis to alleviate myocardial ischemia-reperfusion injury through regulating Syk;Tissue and Cell;2024-12
3. QBT improved cognitive dysfunction in rats with vascular dementia by regulating the Nrf2/xCT/GPX4 and NLRP3/Caspase-1/GSDMD pathways to inhibit ferroptosis and pyroptosis of neurons;International Immunopharmacology;2024-12
4. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation;Biochemical and Biophysical Research Communications;2024-11
5. The phosphorylation of Smad3 by CaMKIIγ leads to the hepatocyte pyroptosis under perfluorooctane sulfonate exposure;Ecotoxicology and Environmental Safety;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3